{"date":"2026-10-08","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4174-2026-10-08-2107-aeaf40","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-10-08","time":"21:07:31","subject":"公告本公司放棄參與鼎晉子公司115年現金增資發行新股轉予本公司全體股東認購一案，訂定其他利益基準日","clause":"第53款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-10-08 21:07，「公告本公司放棄參與鼎晉子公司115年現金增資發行新股轉予本公司全體股東認購一案，訂定其他利益基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-10-08-1908-5ms69j","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-10-08","time":"19:08:49","subject":"本公司受邀參加寬量國際主辦之「20th QIC CEO Week」","clause":"第30款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-10-08 19:08，「本公司受邀參加寬量國際主辦之「20th QIC CEO Week」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-10-08-1809-16g7qjx","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-10-08","time":"18:09:57","subject":"公告本公司初次申請股票上市時所出具之承諾事項暨其後續執行情形","clause":"第51款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-10-08 18:09，「公告本公司初次申請股票上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-10-08-1802-ahhcpl","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-10-08","time":"18:02:44","subject":"公告本公司「用於上呼吸道給藥之組成物及其給藥方法」取得歐洲發明專利","clause":"第44款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-10-08 18:02，「公告本公司「用於上呼吸道給藥之組成物及其給藥方法」取得歐洲發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-10-08-1716-10jca0t","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-10-08","time":"17:16:15","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-10-14","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-10-08 17:16，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-10-08-1713-1o4ew1r","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-10-08","time":"17:13:02","subject":"更正115/06/09法說會簡報資訊部分內容","clause":"第44款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-10-08 17:13，「更正115/06/09法說會簡報資訊部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-10-08-1607-1ww80qa","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-10-08","time":"16:07:35","subject":"公告本公司股票初次上市前現金增資發行新股承銷價格暨暫定承銷價相關事宜","clause":"第44款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-10-08 16:07，「公告本公司股票初次上市前現金增資發行新股承銷價格暨暫定承銷價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-10-08-1603-x3pjnm","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-10-08","time":"16:03:32","subject":"本公司內部稽核主管異動","clause":"第11款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-10-08 16:03，「本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-10-08-1535-h01jn2","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-10-08","time":"15:35:48","subject":"公告本公司第3次買回庫藏股期間屆滿執行情形","clause":"第35款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-10-08 15:35，「公告本公司第3次買回庫藏股期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-10-08-1513-gwakdq","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-10-08","time":"15:13:30","subject":"公告本公司董事會通過預計處分有價證券。","clause":"第20款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-10-08 15:13，「公告本公司董事會通過預計處分有價證券。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-10-08-1443-cz6enw","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-10-08","time":"14:43:44","subject":"本公司受邀參加由寬量國際主辦之「20th QIC CEO Week」","clause":"第12款","fact_date":"2026-10-13","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-10-08 14:43，「本公司受邀參加由寬量國際主辦之「20th QIC CEO Week」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-10-08-1425-1386plu","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-10-08","time":"14:25:34","subject":"本公司與某國際製藥公司簽署主服務合約","clause":"第10款","fact_date":"2026-10-08","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-10-08 14:25，「本公司與某國際製藥公司簽署主服務合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}